Hewlett Js

404 total citations
13 papers, 305 citations indexed

About

Hewlett Js is a scholar working on Oncology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hewlett Js has authored 13 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hewlett Js's work include Acute Lymphoblastic Leukemia research (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer Treatment and Pharmacology (3 papers). Hewlett Js is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer Treatment and Pharmacology (3 papers). Hewlett Js collaborates with scholars based in United States. Hewlett Js's co-authors include Bukowski Rm, Harris Jw, Weick Jk, Jessica St. Louis, Fowler Wm, R. Gahbauer, Baker Lh, R Bottomley, Jones Se and Bodey Gp and has published in prestigious journals such as PubMed.

In The Last Decade

Hewlett Js

12 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hewlett Js United States 9 130 118 100 56 51 13 305
Hiroshi Harano Japan 11 131 1.0× 57 0.5× 44 0.4× 60 1.1× 15 0.3× 38 351
HM Lazarus United States 6 305 2.3× 71 0.6× 143 1.4× 39 0.7× 17 0.3× 7 461
Andrews Df United States 7 175 1.3× 118 1.0× 78 0.8× 110 2.0× 28 0.5× 10 398
Shin Matsuda Japan 10 182 1.4× 47 0.4× 51 0.5× 21 0.4× 12 0.2× 44 321
J Sans-Sabrafén Spain 14 264 2.0× 74 0.6× 52 0.5× 38 0.7× 15 0.3× 51 556
Tadaharu Kanie Japan 10 157 1.2× 108 0.9× 132 1.3× 60 1.1× 9 0.2× 22 369
Chong-Won Park South Korea 14 434 3.3× 221 1.9× 126 1.3× 50 0.9× 70 1.4× 38 619
A Rosenmayr Austria 10 374 2.9× 256 2.2× 97 1.0× 24 0.4× 24 0.5× 20 522
Stefano Volpetti Italy 12 308 2.4× 78 0.7× 67 0.7× 42 0.8× 38 0.7× 26 538
Panagiotis Repoussis Greece 10 177 1.4× 74 0.6× 154 1.5× 67 1.2× 24 0.5× 12 436

Countries citing papers authored by Hewlett Js

Since Specialization
Citations

This map shows the geographic impact of Hewlett Js's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hewlett Js with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hewlett Js more than expected).

Fields of papers citing papers by Hewlett Js

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hewlett Js. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hewlett Js. The network helps show where Hewlett Js may publish in the future.

Co-authorship network of co-authors of Hewlett Js

This figure shows the co-authorship network connecting the top 25 collaborators of Hewlett Js. A scholar is included among the top collaborators of Hewlett Js based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hewlett Js. Hewlett Js is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Js, Hewlett, et al.. (2010). Acromegaly associated with amyotrophic lateral sclerosis and acromegaly of the amyotrophic type.. PubMed. 19. 40–40.
2.
Rm, Bukowski, et al.. (1982). Treatment of severe aplastic anemia with antithymocyte globulin.. PubMed. 10(9). 809–16. 13 indexed citations
3.
Bottomley, R, et al.. (1981). Doxorubicin and ifosfamide combination chemotherapy in previously treated acute leukemia in adults: a Southwest Oncology Group pilot study.. PubMed. 64(8-9). 869–72. 12 indexed citations
4.
Gahbauer, R., et al.. (1981). Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.. PubMed. 65(3-4). 219–22. 28 indexed citations
5.
Rm, Bukowski, et al.. (1980). Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.. PubMed. 3(4). 321–4. 26 indexed citations
6.
Rm, Bukowski, et al.. (1979). Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.. PubMed. 63(5). 795–6. 30 indexed citations
7.
Js, Hewlett, et al.. (1979). Combination 6-mercaptopurine and 6-methylmercaptopurine riboside in the treatment of adult acute leukemia: a Southwest Oncology Group study.. PubMed. 63(1). 156–8. 8 indexed citations
8.
Js, Hewlett, et al.. (1978). Cyclocytidine chemotherapy for malignant melanoma.. PubMed. 62(3). 469–71. 3 indexed citations
9.
Lh, Baker, et al.. (1977). Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.. PubMed. 61(8). 1595–7. 18 indexed citations
10.
Rm, Bukowski, et al.. (1977). Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.. PubMed. 61(7). 1375–7. 4 indexed citations
11.
Gp, Bodey, et al.. (1977). Adriamycin therapy in previously treated adult acute leukemia.. PubMed. 61(5). 905–7. 9 indexed citations
12.
Rm, Bukowski, et al.. (1976). Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura.. PubMed. 13(3). 219–32. 115 indexed citations
13.
Js, Hewlett, et al.. (1964). PHASE II STUDY OF A-8103 (NSC-25154) IN ACUTE LEUKEMIA IN ADULTS.. PubMed. 42. 25–8. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026